Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles

被引:69
作者
Oyewumi, MO [1 ]
Mumper, RJ [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA
关键词
KB cells; emulsifying wax; Brij; 72; surfactant; microemulsion;
D O I
10.1016/S0378-5173(02)00587-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Emulsifying wax and polyoxyl 2 stearyl ether (Brij 72) nanoparticles (2 mg/ml) containing high concentrations of gadolinium hexanedione (GdH) (0-3 mg) have been engineered from oil-in-water microemulsion templates. Solid nanoparticles were cured by cooling warm microemulsion templates (prepared at 55 degreesC) to room temperature in one vessel. Nanoparticles were characterized by transmission electron microscopy (TEM), photon correlation spectroscopy (PCs) and gel permeation chromatography (GPC). To obtain folate-coated nanoparticles, a folate ligand was added to either the microemulsion templates or nanoparticle suspensions at 25 degreesC. Since the concentration of Gd in the tumor is critical to the success of Gd-neutron capture therapy (NCT), the effects of various formulation factors on GdH entrapment in nanoparticles as well as tumor-targeting were studied. GdH entrapment in nanoparticles was affected mostly by the method of GdH incorporation and surfactant concentration used in preparing the microemulsion templates. Cell uptake studies were carried out in KB cells (human nasopharyngeal epidermal carcinoma cell line). The method of adding folate ligand to the formulations did not significantly affect nanoparticle cell uptake (P > 0. 11; t-test). However, the concentration of folate ligand added to nanoparticles had the greatest influence on nanoparticle uptake (P < 0.0 1; t-test). The results showed that GdH entrapment and cell uptake were optimized and suggested that engineered folate-coated nanoparticles may serve as effective carrier systems for Gd-NCT of tumors. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:85 / 97
页数:13
相关论文
共 39 条
[31]  
Stella B, 2000, J PHARM SCI-US, V89, P1452, DOI 10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO
[32]  
2-P
[33]   Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor [J].
Tokumitsu, H ;
Hiratsuka, J ;
Sakurai, Y ;
Kobayashi, T ;
Ichikawa, H ;
Fukumori, Y .
CANCER LETTERS, 2000, 150 (02) :177-182
[34]   Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: Preparation by novel emulsion-droplet coalescence technique and characterization [J].
Tokumitsu, H ;
Ichikawa, H ;
Fukumori, Y .
PHARMACEUTICAL RESEARCH, 1999, 16 (12) :1830-1835
[35]   Comparison of radiation effects of gadolinium and boron neutron capture reactions [J].
Tokuuye, K ;
Tokita, N ;
Akine, Y ;
Nakayama, H ;
Sakurai, Y ;
Kobayashi, T ;
Kanda, K .
STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (02) :81-83
[36]   Folate-mediated targeting of antineoplastic drags, imaging agents, and nucleic acids to cancer cells [J].
Wang, S ;
Low, PS .
JOURNAL OF CONTROLLED RELEASE, 1998, 53 (1-3) :39-48
[37]  
WEITMAN SD, 1992, CANCER RES, V52, P3396
[38]  
WU NZ, 1993, CANCER RES, V53, P3765
[39]   Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain [J].
Yang, SC ;
Lu, LF ;
Cai, Y ;
Zhu, JB ;
Liang, BW ;
Yang, CZ .
JOURNAL OF CONTROLLED RELEASE, 1999, 59 (03) :299-307